Assenagon Asset Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Assenagon Asset Management’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-14,703	Closed	-$46K	–	1619
2021 Q4	$46K	Sell	14,703 -108,813	-88%	-$366K	﹤0.01%	1406
2021 Q3	$446K	Sell	123,516 -2,131	-2%	-$8.04K	﹤0.01%	1086
2021 Q2	$450K	Sell	125,647 -92,062	-42%	-$325K	﹤0.01%	1053
2021 Q1	$851K	Sell	217,709 -183	-0.1%	-$756	﹤0.01%	955
2020 Q4	$915K	Sell	217,892 -595,868	-73%	-$2.3M	﹤0.01%	767
2020 Q3	$3.04M	Buy	813,760 +247,665	+44%	+$1.05M	0.02%	480
2020 Q2	$2.47M	Buy	566,095 +555,542	+5,264%	+$2.5M	0.02%	535
2020 Q1	$40K	Sell	10,553 -378,265	-97%	-$1.86M	﹤0.01%	748
2019 Q4	$2.46M	Buy	+388,818	New	+$2.29M	0.02%	385
2019 Q3	–	Sell	-1,532,300	Closed	-$7.13M	–	1185
2019 Q2	$7.13M	Buy	+1,532,300	New	+$7.13M	0.05%	214

Other funds holding BDSI

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

FCMT

Founders Capital Management (Texas) Houston, Texas $231M AUM 61.68% 1-Year Est. Return

Assenagon Asset Management's BDSI Position: Q1 2022 in Review

Assenagon Asset Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 14,703 shares — an estimated $46K sold.

Assenagon Asset Management first reported a position in BDSI in Q2 2019 and held it in 10 quarters. The position peaked at $7.13M in Q2 2019. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.

Assenagon Asset Management reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
Assenagon Asset Management sold 14,703 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $46K.
Assenagon Asset Management first reported a position in BioDelivery Sciences International, Inc. in Q2 2019 and held it in 10 quarters.
Assenagon Asset Management's BioDelivery Sciences International, Inc. position peaked at $7.13M in Q2 2019.
2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.

Based on Assenagon Asset Management's 13F filing for Q1 2022, filed 25 Apr 2022.